KalVista Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KALV and other ETFs, options, and stocks.

About KALV

KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa.

CEO

Benjamin L. Palleiko

CEOBenjamin L. Palleiko

Employees

270

Employees270

Headquarters

Framingham, Massachusetts

HeadquartersFramingham, Massachusetts

Founded

2004

Founded2004

Employees

270

Employees270

KALV Key Statistics

Market cap

753.33M

Market cap753.33M

Price-Earnings ratio

-3.52

Price-Earnings ratio-3.52

Dividend yield

—

Dividend yield—

Average volume

979.05K

Average volume979.05K

High today

$13.83

High today$13.83

Low today

$13.19

Low today$13.19

Open price

$13.69

Open price$13.69

Volume

844.55K

Volume844.55K

52 Week high

$16.32

52 Week high$16.32

52 Week low

$7.30

52 Week low$7.30

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own KALV. This list is generated using Robinhood data, and it’s not a recommendation.